Michel White
#180,419
Most Influential Person Now
Researcher
Michel White's AcademicInfluence.com Rankings
Michel Whitecomputer-science Degrees
Computer Science
#11376
World Rank
#12047
Historical Rank
Machine Learning
#5207
World Rank
#5273
Historical Rank
Artificial Intelligence
#5615
World Rank
#5697
Historical Rank
Database
#8396
World Rank
#8785
Historical Rank
Download Badge
Computer Science
Michel White's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Michel White Influential?
(Suggest an Edit or Addition)Michel White's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Trials (2003) (602)
- Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. (1996) (472)
- Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. (2006) (452)
- Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) Trial (2010) (309)
- Age‐Related Changes in β‐Adrenergic Neuroeffector Systems in the Human Heart (1994) (278)
- Effects of Right Ventricular Ejection Fraction on Outcomes in Chronic Systolic Heart Failure (2010) (265)
- Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. (2000) (263)
- Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study. (2000) (218)
- Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial (2005) (178)
- Enalapril Reduces the Incidence of Diabetes in Patients With Chronic Heart Failure: Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) (2003) (173)
- Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage. (1995) (159)
- Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. (2007) (158)
- Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. (2008) (153)
- Left Ventricular Versus Simultaneous Biventricular Pacing in Patients With Heart Failure and a QRS Complex ≥120 Milliseconds (2011) (127)
- Cardiac Resynchronization Therapy in Patients With Heart Failure and a QRS Complex <120 Milliseconds: The Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) Trial (2013) (126)
- Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD). (2003) (121)
- Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat. (1998) (119)
- Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial. (2008) (118)
- Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. (2008) (116)
- The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications. (2015) (108)
- Impact of better adherence to statin agents in the primary prevention of coronary artery disease (2009) (100)
- Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support. (2006) (95)
- Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy. (1995) (93)
- Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. (2009) (93)
- Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure. (2011) (88)
- High-intensity interval exercise in chronic heart failure: protocol optimization. (2012) (86)
- Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity‐matched study (2011) (85)
- The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure. (2003) (85)
- The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure. (2001) (79)
- Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial. (2009) (75)
- The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction). (2015) (75)
- Decreased heart rate recovery after exercise in patients with congestive heart failure: effect of beta-blocker therapy. (2003) (72)
- Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure. (2003) (71)
- A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study. (2009) (69)
- Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both. (2005) (68)
- Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting. (2009) (67)
- Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial. (2007) (67)
- Better adherence to antihypertensive agents and risk reduction of chronic heart failure (2009) (65)
- Adherence level of antihypertensive agents in coronary artery disease. (2010) (64)
- Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure. (2013) (64)
- Aging and cardiovascular responsiveness to β‐agonist in humans: Role of changes in β‐receptor responses versus baroreflex activity (1994) (63)
- A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation. (1999) (60)
- Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial. (2013) (56)
- Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials. (2006) (55)
- Combinatorial Pharmacogenetic Interactions of Bucindolol and β1, α2C Adrenergic Receptor Polymorphisms (2012) (53)
- Age- and gender-related changes in endothelin and catecholamine release, and in autonomic balance in response to head-up tilt. (1997) (51)
- Isolated Diastolic Hypotension and Incident Heart Failure in Older Adults (2011) (50)
- Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure. (2008) (48)
- Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure (2010) (48)
- Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking. (2015) (48)
- The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: focus on rehabilitation and exercise and surgical coronary revascularization. (2014) (47)
- Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure. (2016) (45)
- Care Gaps in Adherence to Heart Failure Guidelines: Clinical Inertia or Physiological Limitations? (2020) (45)
- Effects of combined candesartan and ACE inhibitors on BNP, markers of inflammation and oxidative stress, and glucose regulation in patients with symptomatic heart failure. (2007) (44)
- 2001 Canadian Cardiovascular Society Consensus Conference on cardiac transplantation. (2003) (43)
- Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction. (2001) (41)
- Effect of everolimus on the immunomodulation of the human neutrophil inflammatory response and activation (2014) (41)
- Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion. (2005) (40)
- Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary. (2009) (40)
- Heart Failure With Anemia: Novel Findings on the Roles of Renal Disease, Interleukins, and Specific Left Ventricular Remodeling Processes (2014) (40)
- Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial). (2010) (39)
- Prognostic value of the physical examination in patients with heart failure and atrial fibrillation: insights from the AF-CHF trial (atrial fibrillation and chronic heart failure). (2014) (38)
- Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation (2013) (38)
- Reduced pulmonary clearance of endothelin in congestive heart failure: a marker of secondary pulmonary hypertension. (2004) (37)
- Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction. (2019) (36)
- An Open-Label Study of Nefazodone Treatment of Major Depression in Patients with Congestive Heart Failure (2003) (36)
- Sternal wound infection after heart transplantation: incidence and results with aggressive surgical treatment. (2001) (36)
- Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure. (2016) (36)
- Effects of AGTR1 A1166C Gene Polymorphism in Patients with Heart Failure Treated with Candesartan (2008) (35)
- Lack of long-term benefits of a 6-month heart failure disease management program. (2007) (35)
- Orthostatic hypotension and incident heart failure in community-dwelling older adults. (2014) (34)
- Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves. (2011) (34)
- Incidence and prognosis of cancer following heart transplantation using RATG induction therapy (2005) (34)
- Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation. (2013) (34)
- Impact of adherence to statins on chronic heart failure in primary prevention. (2008) (33)
- Exercise for Solid Organ Transplant Candidates and Recipients: A Joint Position Statement of the Canadian Society of Transplantation and CAN-RESTORE. (2019) (32)
- Decreased coronary sinus oxygen content: a predictor of adverse prognosis in patients with severe congestive heart failure. (1991) (32)
- An Internet-Based Counseling Intervention With Email Reminders that Promotes Self-Care in Adults With Chronic Heart Failure: Randomized Controlled Trial Protocol (2014) (31)
- Effect of serum insulin on the association between hyperuricemia and incident heart failure. (2010) (31)
- Up-regulation of beta 2-adrenergic receptors in previously transplanted, denervated nonfailing human hearts. (1993) (31)
- Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients. (2008) (30)
- Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction. (2017) (30)
- Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation. (2017) (29)
- Cardiac transplantation for hypertrophic cardiomyopathy: a valid therapeutic option. (2004) (29)
- Aging and cardiovascular responsiveness to beta-agonist in humans: role of changes in beta-receptor responses versus baroreflex activity. (1994) (29)
- Pharmacokinetics in stable heart transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations. (2011) (28)
- Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST]). (2010) (27)
- Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients. (1997) (27)
- Impaired endothelin-1 release in tilt-induced syncope. (1998) (26)
- Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction. (2012) (26)
- Reduction of cyclosporine following the introduction of everolimus in maintenance heart transplant recipients: a pilot study (2010) (26)
- Effects of age and hypertension on cardiac responses to the alpha1-agonist phenylephrine in humans. (1999) (26)
- Association between renal function and CYP3A5 genotype in heart transplant recipients treated with calcineurin inhibitors. (2011) (25)
- Digoxin and reduction of heart failure hospitalization in chronic systolic and diastolic heart failure. (2008) (25)
- Blood Pressure and Atrial Fibrillation: A Combined AF‐CHF and AFFIRM Analysis (2015) (25)
- Heart rate recovery--a potential marker of clinical outcomes in heart failure patients receiving beta-blocker therapy. (2007) (25)
- Acute Heart Failure: Perspectives From a Randomized Trial and a Simultaneous Registry (2012) (23)
- Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol). (2003) (23)
- Subclinical Inflammation and Prothrombotic State in Heart Transplant Recipients: Impact of Cyclosporin Microemulsion vs. Tacrolimus (2006) (23)
- A propensity-matched study of elevated jugular venous pressure and outcomes in chronic heart failure. (2009) (23)
- The Canadian Study of Cardiac Transplantation. Atherosclerosis. Investigators of the CASCADE Study. (1999) (22)
- Relationship between left and right ventricular ejection fractions in chronic advanced systolic heart failure: insights from the BEST trial (2011) (22)
- Effects of age on cardiovascular responses to adrenaline in man. (1997) (22)
- Synthesis of Human Neutrophil Extracellular Traps Contributes to Angiopoietin-Mediated In Vitro Proinflammatory and Proangiogenic Activities (2018) (21)
- Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: Insights from the Cardiovascular Health Study. (2017) (21)
- Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF). (2008) (21)
- Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study. (2017) (21)
- Risk Factors for Chronic Renal Insufficiency Following Cardiac Transplantation. (2015) (21)
- Pregnancy after heart transplantation: a well‐thought‐out decision? The Quebec provincial experience – a multi‐centre cohort study (2018) (19)
- Second- and Third-Generation Beta-Blocking Drugs in Chronic Heart Failure (1997) (19)
- CRP Induces NETosis in Heart Failure Patients with or without Diabetes (2019) (18)
- Comparison of the beta blocker bucindolol in younger versus older patients with heart failure. (2002) (18)
- Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population : The GENETIC-AF Trial (2019) (18)
- Impact of ezetimibe on cholesterol subfractions in dyslipidemic cardiac transplant recipients receiving statin therapy (2009) (18)
- Enantioselective quantification of carvedilol in human plasma by HPLC in heavily medicated heart failure patients. (2010) (18)
- Effect of warfarin on outcomes in septuagenarian patients with atrial fibrillation. (2012) (17)
- Hemodynamic and clinical benefits associated with chronic sildenafil therapy in advanced heart failure: experience of the Montréal Heart Institute. (2012) (17)
- Cardiac Resynchronization Therapy in Patients with Heart Failure and a QRS Complex <120 ms: the LESSER-EARTH Trial (2013) (17)
- Long‐term evolution, secular trends, and risk factors of renal dysfunction following cardiac transplantation (2014) (17)
- Changes in Cardiopulmonary Reserve and Peripheral Arterial Function Concomitantly with Subclinical Inflammation and Oxidative Stress in Patients with Heart Failure with Preserved Ejection Fraction (2014) (17)
- Mineralocorticoid Receptor Antagonists and Cardiovascular Mortality in Patients With Atrial Fibrillation and Left Ventricular Dysfunction: Insights From the Atrial Fibrillation and Congestive Heart Failure Trial (2012) (17)
- Similar clinical benefits from below‐target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial (2018) (17)
- Comparison of Neoral and Sandimmune cyclosporine for induction of immunosuppression after heart transplantation. (1997) (17)
- Results following implantation of mechanical circulatory support systems: the Montreal Heart Institute experience. (2009) (16)
- Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure. (2005) (16)
- Effect of mycophenolate mofetil in heart transplantation. (2000) (16)
- Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST). (2007) (16)
- Mediastinal and Pericardial Complications after Heart Transplantation. Not-So-Unusual Postoperative Problems? (1994) (16)
- Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone. (2017) (16)
- Sex-related differences in age-associated downregulation of human ventricular myocardial β1-adrenergic receptors. (2016) (15)
- Evaluation of resynchronization therapy for heart failure in patients with a QRS duration greater than 120 ms (GREATER-EARTH) trial: rationale, design, and baseline characteristics. (2011) (15)
- Right ventricular ejection fraction <20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients. (2012) (15)
- Seven-year experience with rabbit antithymocyte globulin after cardiac transplantation at the Montreal Heart Institute. (1997) (15)
- Risk of Heart Failure and Death After Prolonged Smoking CessationCLINICAL PERSPECTIVE (2015) (14)
- Therapeutic potential of angiotensin II receptor antagonists (2001) (14)
- Bucindolol, systolic blood pressure, and outcomes in systolic heart failure: a prespecified post hoc analysis of BEST. (2012) (14)
- Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving β-blockers: insights from the BEST trial. (2013) (13)
- Systolic blood pressure and mortality in patients with atrial fibrillation and heart failure: insights from the AFFIRM and AF‐CHF studies (2014) (13)
- Subclinical Inflammation in Heart Failure: A Neutrophil Perspective. (2018) (13)
- Cardiac remodeling with rhythm versus rate control strategies for atrial fibrillation in patients with heart failure: insights from the AF-CHF echocardiographic sub-study. (2013) (13)
- Opinions, hopes and concerns regarding pharmacogenomics: a comparison of healthy individuals, heart failure patients and heart transplant recipients (2014) (13)
- Angiotensin II signalling and calcineurin in cardiac fibroblasts: differential effects of calcineurin inhibitors FK506 and cyclosporine A (2012) (13)
- Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker (2009) (13)
- Ten-year follow-up of critically ill patients undergoing heart transplantation. (2000) (12)
- Experience with the SynCardia total artificial heart in a Canadian centre (2017) (12)
- Temporal increases in subclinical levels of inflammation are associated with adverse clinical outcomes in patients with left ventricular dysfunction. (2006) (12)
- Cardiac signaling molecules and plasma biomarkers after cardiac transplantation: impact of tacrolimus versus cyclosporine. (2013) (12)
- Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy. (2005) (12)
- PRKCB is associated with calcineurin inhibitor-induced renal dysfunction in heart transplant recipients (2012) (11)
- Myocardial Vascular Function Assessed by Dynamic Oxygenation-sensitive Cardiac Magnetic Resonance Imaging Long-term Following Cardiac Transplantation. (2020) (11)
- Additive Effects of β1 389 Arg/Gly α2c 322–325 Wt/Del Genotype Combinations on Adjudicated Hospitalizations and Death in the Beta-Blocker Evaluation of Survival Trial (BEST) (2008) (10)
- Association between smoking and outcomes in older adults with atrial fibrillation. (2012) (10)
- Antithymocyte globulin and methotrexate therapy of severe or persistent cardiac allograft rejection. (1995) (10)
- Cold temperature impairs maximal exercise performance in patients with heart failure: attenuation by acute ACE inhibitor therapy. (2002) (10)
- A genotype‐directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC‐AF trial (2017) (10)
- Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial. (2017) (9)
- Cardioprotective effect of angiotensin II receptor antagonists. (1999) (9)
- Automated E-Counseling for Chronic Heart Failure: CHF-CePPORT Trial. (2021) (9)
- Successful management strategy for mechanical assistance and heart transplantation in patients suffering from heparin-induced thrombocytopenia type II. (2001) (9)
- Conversion of cyclosporine A to tacrolimus following heart transplantation. (1999) (9)
- HEARTBiT: A Transcriptomic Signature for Excluding Acute Cellular Rejection in Adult Heart Allograft Patients. (2019) (9)
- Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure. (1994) (9)
- New Insights into the Pro-Inflammatory Activities of Ang1 on Neutrophils: Induction of MIP-1β Synthesis and Release (2016) (8)
- Effect of left ventricular assist device bridging to transplantation on donor waiting time and outcomes in Canada. (2004) (8)
- Rheumatic heart disease and risk of incident heart failure among community-dwelling older adults: A prospective cohort study (2012) (8)
- Age, hypertension, and cardiac responses to β‐agonist in humans (1998) (7)
- A prospective study of the impact of AGTR1 A1166C on the effects of candesartan in patients with heart failure. (2018) (7)
- Optimal Usage of Sacubitril/Valsartan for the Treatment of Heart Failure: The Importance of Optimizing Heart Failure Care in Canada (2020) (7)
- Cerebral Hemodynamics During Exercise and Recovery in Heart Transplant Recipients. (2016) (7)
- Effect of pentoxifylline on renal toxicity of cyclosporine: results of a clinical trial after heart transplantation. (1996) (7)
- Neutrophils pro‐inflammatory and anti‐inflammatory cytokine release in patients with heart failure and reduced ejection fraction (2021) (7)
- A comparison of the effects of selective and non‐selective mineralocorticoid antagonism on glucose homeostasis of heart failure patients with glucose intolerance or type II diabetes: A randomized controlled double‐blind trial (2018) (6)
- Is there a potential association between spironolactone and the risk of new-onset diabetes in a cohort of older patients with heart failure? (2019) (6)
- Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring--further insights from SOLVD. (2008) (6)
- Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatment. (2002) (6)
- A genetic association study of heart failure: more evidence for the role of BAG3 in idiopathic dilated cardiomyopathy (2020) (6)
- Right ventricular function and its coupling to pulmonary circulation predicts exercise tolerance in systolic heart failure (2021) (6)
- GENETIC-AF: Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined Heart Failure Population. (2019) (5)
- Sirolimus Immunoprophylaxis and Renal Histological Changes in Long-Term Cardiac Transplant Recipients (2014) (5)
- Hyperventilation-induced heart rate response as a potential marker for cardiovascular disease (2019) (5)
- Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality (2017) (4)
- Forearm reactive hyperemic blood flow and arm-cranking exercise capacity in healthy and heart failure subjects. (2002) (4)
- Cardiac beta receptors and baroreflex responses with aging (1991) (4)
- Cardiorespiratory Fitness Mediates Cognitive Performance in Chronic Heart Failure Patients and Heart Transplant Recipients (2020) (4)
- Two decades of cardiac transplantation at the Montreal Heart Institute. (2008) (4)
- Myocyte growth, repair, and oxidative stress following pediatric heart transplantation (2014) (4)
- DISCHARGE INITIATION OF ACE INHIBITORS OR ARBS IS ASSOCIATED WITH SIGNIFICANTLY LOWER 30-DAY ALL-CAUSE READMISSION IN HOSPITALIZED OLDER PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION (2014) (4)
- Temporal Changes on the Risks and Complications of Posttransplantion Diabetes Mellitus Following Cardiac Transplantation (2018) (4)
- Age, hypertension, and cardiac responses to beta-agonist in humans. (1998) (3)
- Prognostic Value of the Physical Examination in Patients with Heart Failure and Atrial Fibrillation: Insights from the AF-CHF Trial (2013) (3)
- Comparison of cyclosporine and tacrolimus in combination with rabbit antithymocyte immunoglobulins as induction therapy in cardiac transplantation. (2009) (3)
- Care processes and structures associated with higher medication adherence in adolescent and young adult transplant recipients (2021) (3)
- A Cardiac and a Kidney Transplant Patient Above 6000 Meters in Bolivia (2009) (3)
- Development of a Focused Pharmacogenomics Panel To Predict the Effects of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Heart Failure (2007) (3)
- Effects of Angiotensin-Converting Enzyme Inhibitor Versus Valsartan on Cellular Signaling Events in Heart Transplant (2009) (3)
- Emphasis on abdominal obesity as a modifier of eplerenone effect in heart failure: hypothesis‐generating signals from EMPHASIS‐HF (2017) (3)
- 511 Similar remodeling benefit of LV-CRT and BiV-CRT in patients with heart failure and wide qrs: Insight from the evaluation of resynchronization therapy for heart failure (EARTH) trial (2011) (2)
- An unusual case of giant cell myocarditis missed in a Heartmate-2 left ventricle apical-wedge section: a case report and review of the literature (2013) (2)
- Changes in patient characteristics following cardiac transplantation: the Montreal Heart Institute experience (2017) (2)
- 514 Blood Pressure and Atrial Fibrillation: A Combined AF-CHF and Affirm Analysis (2012) (2)
- Effects of immunosuppressive agents on neutrophils inflammatory response in humans: an inflammatory perspective on coronary allograft vasculopathy (2016) (2)
- The impact of serum digoxin concentration and enalapril therapy in patients with CHF: the SOLVD trial revisited (2004) (2)
- ACUTE CORONARY SYNDROMES IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: A HARBINGER OF DEATH? (2010) (2)
- Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the ADRB1 Arg389Arg Genotype (2021) (2)
- AN EVALUATION OF THE EFFECT OF SPIRONOLACTONE ON THE RISK OF NEW-ONSET DIABETES IN A POPULATION-BASED STUDY OF PATIENTS WITH HEART FAILURE (2016) (2)
- Persistent Elevation of VEGF and Prostacyclin Following Poor Cardiopulmonary Adaptation to High Altitude (2009) (2)
- Overview of clinical trials in congestive heart failure. (1993) (2)
- Successful explantation of a left ventricular assist device following acute fulminant myocarditis. (2006) (2)
- Decreased circulating and neutrophil mediated VEGF-A165 release in stable long-term cardiac transplant recipients (2015) (2)
- Corrigendum to "Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the cardiovascular health study" [Int. J. Cardiol. 235 (2017) 11-16]. (2017) (2)
- Metoprolol CR/XL, in addition to optimum standard therapy, improved survival in patients with symptomatic HF (1999) (1)
- PROTOTYPICAL TRAJECTORIES OF PATIENT ENGAGEMENT WITH AN E-COUNSELLING PLATFORM TO PROMOTE SELF-CARE IN HEART FAILURE (2015) (1)
- CHANGES IN PREVALENCE, PROGRESSION AND OUTCOMES OF CORONARY ALLOGRAFT VASCULOPATHY OVER 25 YEARS FOLLOWING CARDIAC TRANSPLANTATION: A SINGLE CENTER EXPERIENCE (2017) (1)
- Risk of Mortality and Hospital Readmission Among Older Adults with Heart Failure Treated with Carvedilol, Bisoprolol or Metoprolol Tartrate (2016) (1)
- ORTHOSTATIC HYPOTENSION: A NEW RISK FACTOR FOR INCIDENT HEART FAILURE IN COMMUNITY-DWELLING OLDER ADULTS (2011) (1)
- RIGHT VENTRICULAR FUNCTION COUPLING TO THE PULMONARY CIRCULATION PREDICTS EXERCISE TOLERANCE IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION: INSIGHT FROM THE EVALUATION OF RESYNCHRONIZATION THERAPY FOR HEART FAILURE (EARTH) TRIAL (2020) (1)
- 513 Elevated Osteopontin Levels in Patients With Chronic Heart Failure: Describing a Specific Physiopathologal Process (2012) (1)
- Natriuretic peptides predict left ventricular remodeling in response to metoprolol CR in patients with congestive heart failure: the RESOLVD phase II neurohumoral substudy (2002) (1)
- Abstract 901: Effects of Bucindolol on Cardiovascular Mortality and Morbidity are Determined by the Beta-1 389 Arg/Gly Receptor Polymorphism (2007) (1)
- Abstract 18649: Comparative Impact of Isolated Systolic Hypertension vs Systolic-Diastolic Hypertension on Incident Heart Failure and All-Cause Mortality in Community-Dwelling Older Adults (2014) (1)
- CYP3A5*1/*3 Genetic Polymorphism Is Associated with Post Cardiac Transplant Renal Dysfunction in Patients Treated with Calcineurin Inhibitors (2008) (1)
- 1012-129 Dual angiotensin-II suppression with angiotensin-converting enzyme inhibitor and irbesartan improves submaximal exercise time without changes in exercise-induced neurohumoral response in patients with congestive heart failure (2004) (1)
- Cardiopulmonary, biomarkers, and vascular responses to acute hypoxia following cardiac transplantation (2018) (1)
- Treating major depression in congestive heart failure: An open-label trial of nefazodone (1999) (1)
- Prograf decreases plasma cholesterol in heart transplant recipients with treated but persisting mild dyslipidemia: the canadian multicenter randomized trial of prograf versus neoral (2003) (1)
- Baseline Hypokalemia and Long-Term Outcomes in Ambulatory Patients with Heart Failure with Reduced Ejection Fraction (HFrEF) and New York Heart Association Class III-IV: A Propensity-Matched Study of Beta-Blocker Evaluation of Survival Trial (BEST) (2016) (1)
- PATIENT ENGAGEMENT WITH E-COUNSELLING PROMOTES SELF-CARE IN HEART FAILURE (2016) (1)
- Heart Failure Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction (2010) (1)
- Effects of an aerobic and resistance training program on functional capacity and glucose regulation in patients with heart failure and diabetes (2012) (1)
- Blood Test to Monitor for the Absence of Acute Cardiac Rejection: From Discovery to Clinical Implementation (2014) (1)
- Racial differences in mortality in patients with advanced systolic heart failure: potential role of right ventricular ejection fraction. (2014) (1)
- LOW RIGHT VENTRICULAR EJECTION FRACTION: A POTENTIAL EXPLANATION FOR RACIAL DIFFERENCES IN MORTALITY IN ADVANCED SYSTOLIC HEART FAILURE IN THE BETA-BLOCKER EVALUATION OF SURVIVAL TRIAL (2013) (1)
- Population Pharmacokinetics of Candesartan in Patients with Chronic Heart Failure (2020) (1)
- Digoxin in Chronic Systolic and Diastolic Heart Failure: Similar Effects? (2008) (1)
- Determination of Hospitalization Type by Investigator Case Report Form or Adjudication Committee in a Large Heart Failure Clinical Trial (BEST) (2008) (1)
- 125 Absence of Remodeling Benefit of LV-CRT over BiV-CRT in Patients with Heart Failure and Wide QRS: Insight from the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) TRIAL (2011) (0)
- Secular Trends and Outcome of Isolated versus Combined Type 2 Pulmonary Hypertension in Patients with End-Stage Heart Failure (2019) (0)
- HEARTBIT (2018) (0)
- BLOOD PRESSURE LEVELS MODULATE MORTALITY IN PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE WITH DEPRESSED BUT NOT IN PATIENTS WITH PRESERVED EJECTION FRACTION (2013) (0)
- IS ISOLATED DIASTOLIC HYPOTENSION A NEW RISK FACTOR FOR INCIDENT HEART FAILURE IN COMMUNITY-DWELLING OLDER ADULTS? (2010) (0)
- Hemodynamic responses and neurohormonal activation in “responders” vs. “non-responders” to triple neurohormonal blockade in congestive heart failure (2004) (0)
- Abstract 411: Decreased Circulating and Neutrophil Mediated Vegf Release in Stable Long-term Cardiac Transplant Recipients (2015) (0)
- Angiopoietin 1 release from human neutrophils is independent from neutrophil extracellular traps (NETs) (2021) (0)
- 82 Blood-Based Biomarker Panels for Diagnosis of Acute Heart Allograft Rejection (2012) (0)
- Angiopoietin 1 release from human neutrophils is independent from neutrophil extracellular traps (NETs) (2021) (0)
- THE IMPACT OF T1 MAPPING SEQUENCE SELECTION ON CLINICAL RESULT INTERPRETATION IN CARDIAC TRANSPLANT RECIPIENTS (2016) (0)
- EFFECTS OF COLCHICINE ON INFLAMMATION AND MICROVASCULAR DYSFUNCTION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (2023) (0)
- Impairments of Ventilatory Adaptation at the Onset of a Fixed Load Exercise Protocol in Patients with Heart Failure (2004) (0)
- 508 Acute heart failure: Canadian perspectives from an RCT and a registry (2011) (0)
- 694 Characterization and functional implications of heart rate increase at the onset of exercise testing and heart rate recovery in patients with advanced heart failure (2011) (0)
- Differences in Concentrations and Correlations amongst Biomarkers of Neurohormonal Activation, Inflammation and Extracellular Matrix Turnover in Patients with HF and a Reduced or a Preserved Left Ventricular Ejection Fraction (2008) (0)
- Use of Antioxidants in Patients with Congestive Heart Failure (2006) (0)
- Age related increase in angiotensin-II type 1 receptor density in arterial vasculature in rats (1998) (0)
- Temporal Changes on the Risk of New Onset Diabetes Following Cardiac Transplantation Over 30 Years (2016) (0)
- 454 Long-term renal effects of switching cardiac transplant patients with cni-induced renal dysfunction to sirolimus: a single center prospective study (2011) (0)
- RED CELL DISTRIBUTION WIDTH IN HEART FAILURE: A MULTIMARKER OF DIFFERENT PATHOPHYSIOLOGICAL PATHWAYS (2014) (0)
- A PROSPECTIVE INVESTIGATION OF THE IMPACT OF AGTR1 A1166C ON THE NEUROHORMONAL AND HEMODYNAMIC EFFECTS OF CANDESARTAN IN HEART FAILURE PATIENTS (2016) (0)
- INCREASE NEUTROPHIL EXTRACELLULAR TRAPS (NETS) RELEASE IN PATIENTS WITH HEART FAILURE AND DIABETES (2016) (0)
- 664 Secular Trends of Renal Dysfunction and Its Risk Factors in Heart Transplantation (2012) (0)
- Clinical and Biochemistry Determinants for Bnp and Renin-Angiotensin-Aldosterone Activation in Patients With Heart Failure (2013) (0)
- 221: Conversion from calcineurin inhibitors to Sirolimus improves renal function in heart transplant recipients with de novo renal dysfunction (2006) (0)
- Neutrophils and Circulating Inflammatory Biomarkers in Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction. (2022) (0)
- 353 Impact of Changes in Pulmonary Pressure and Biomarkers in Response to Acute Normobaric Hypoxia on the Adaptation to an High Altitude Environment (2012) (0)
- Predictors of Neurohormonal and Hemodynamic Effects of Candesartan in Hf Patients Treated With an Ace Inhibitor (2013) (0)
- Lab methods, progression & risk factors for CKD - 2 (2009) (0)
- P2080Cardiopulmonary, vascular and biomarker responses to acute hypoxic stress following cardiac transplantation (2017) (0)
- An Evaluation of the Effect of Spironolactone on the Risk of New-Onset Diabetes in a Cohort of Patients with Heart Failure (2016) (0)
- Association of Treatment with Carvedilol, Bisoprolol and Metoprolol on the Risk of Mortality and Hospital Admission Among Older Adults with Heart Failure. (2015) (0)
- 91 Design of the randomized evaluation of strategies for left ventricular dysfunction (resolvd) pilot study: A trial of combination neurohormonal blockade in patients with congestive heart failure (1997) (0)
- Changes in Plasma Biomarkers of Inflammation, Oxidative Stress and Thrombosis Following De Novo Cardiac Transplantation: Effects of Immunosuppressive Therapy (2010) (0)
- Effect of Spironolactone on The Risk of New Onset of Diabetes Among Patients with Heart Failure: A Population-Based Study (2016) (0)
- Risk Factors of Renal Dysfunction Following Cardiac Transplantation (2013) (0)
- Heart rate recovery correlates with peak oxygen consumption in heart failure patients referred for cardiopulmonary exercise testing (2004) (0)
- Cardiac inhibitory response to alpha stimulation is blunted in young patients with essential hypertension. (1996) (0)
- Effect of pentoxifylline on renal toxicity of cyclosporine: preliminary results. (1994) (0)
- Effect of Reduced Right Ventricular Ejection Fraction on Mortality in Advanced Systolic Heart Failure (2009) (0)
- 474: Assessing safety and efficacy of Neoral®/everolimus maintenance therapy in cardiac transplant recipients: 12 month data (2007) (0)
- Abstract 20782: Discharge Hospice Referral is Associated With Lower 30-Day All-Cause Readmission in Hospitalized Patients With Heart Failure: A Propensity-Matched Study of the Medicare-Linked OPTIMIZE-HF (2016) (0)
- Abstract 18350: Impact of Amount vs Duration of Smoking on Incident Heart Failure and Mortality Among Community-dwelling Older Adults: Need to Reassess the Role of Pack-years as a Tool to Estimate Smoking (2015) (0)
- Abstract 20566: Lower Discharge Systolic Blood Pressure (SBP) and Poor Outcomes among Hospitalized Patients With Heart Failure and Preserved Ejection Fraction (HFpEF) and Stable Admission-to-Discharge SBP (2016) (0)
- INCREASE IN CIRCULATING AND NEUTROPHIL-MEDIATED RELEASE OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN PATIENTS WITH ADVANCED HEART FAILURE (2014) (0)
- Dose-limiting, adverse event–associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial (2021) (0)
- Abstract 4863: Rhythm Versus Rate Control Strategies In Heart Failure Patients With Atrial Fibrillation: Impact On Lv Function And Functional Status: Echocardiographic Insights From Af-chf (2008) (0)
- ORTHOPNEA OR PAROXYSMAL NOCTURNAL DYSPNEA IN OLDER ADULTS WITHOUT PREVALENT HEART FAILURE IS A PREDICTOR, BUT NOT AN INDEPENDENT RISK FACTOR FOR INCIDENT HEART FAILURE: INSIGHTS FROM THE CARDIOVASCULAR HEALTH STUDY (2017) (0)
- Heart Failure Hospitalization (HFH) Despite Digoxin Therapy Versus No HFH Despite Placebo in the Digitalis Investigation Group (DIG) Trial: Insights Into Risk Factors for HFH in hf and Reduced Ejection Fraction (HFrEF) (2017) (0)
- Abstract 20721: Death Despite Enalapril Therapy vs. Survival Despite Placebo in the Studies of Left Ventricular Dysfunction (SOLVD) Trial: Insights into the Role of Traditional Risk Factors for Mortality in Heart Failure and Reduced Ejection Fraction (HFrEF) (2016) (0)
- BASELINE SYSTOLIC BLOOD PRESSURE AND OUTCOMES IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION - RESULTS FROM THE I-PRESERVE TRIAL (2010) (0)
- CEREBRAL OXYGENATION/PERFUSION, CARDIOPULMONARY AND HEMODYNAMIC RESPONSES DURING MAXIMAL INCREMENTAL EXERCISE IN HEART TRANSPLANT RECIPIENTS VS. HEALTHY CONTROL SUBJECTS (2014) (0)
- CHRONIC ALPHA BLOCKER USE AND OUTCOMES IN OLDER MALE MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE (2017) (0)
- Abstract 17212: 30-day All-cause Readmission is Associated With a Significantly Higher Subsequent All-cause Mortality and Costly Readmissions Among Older Medicare Beneficiaries Hospitalized for Heart Failure (2015) (0)
- VEGF CIRCULATING LEVELS AND NEUTROPHIL-MEDIATED VEGF RELEASE IN PATIENTS WITH HEART FAILURE: IMPACT OF HF PHENOTYPE AND DIABETES (2016) (0)
- TEMPORAL CHANGES IN CARDIAC MOLECULAR EVENTS AND BIOMARKERS FOLLOWING DE NOVO CARDIAC TRANSPLANTATION (2011) (0)
- Abstract 20774: Discharge Heart Rate and Outcomes in Hospitalized Patients With Heart Failure and Preserved Ejection Fraction (HFpEF) and Stable Admission-to-Discharge Heart Failure (2016) (0)
- Failure Effects of Right Ventricular Ejection Fraction on Outcomes in Chronic Systolic (2010) (0)
- Lower Discharge Systolic Blood Pressure (SBP) and Poor Outcomes Among Hospitalized Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) and Stable Admission-to Discharge SBP (2017) (0)
- Cyclosporine Dose Reduction in Maintenance Heart Transplant Patients Following Conversion from MMF/Azathioprine to Everolimus (2007) (0)
- Hemodynamic Benefits of Chronic Sildenafil Therapy in Advanced Heart Failure (HF): A Multi-Center Experience (2013) (0)
- EVIDENCE FOR DIFFUSE MYOCARDIAL FIBROSIS IN CARDIAC TRANSPLANT RECIPIENTS ASSESSED BY T1 MAPPING CARDIAC MAGNETIC RESONANCE (2016) (0)
- 647 High Prevalence of Hypertensive Nephropathy in Cardiac Transplant Recipients Selected for Sirolimus Immunoprophylaxis (2012) (0)
- Carvedilol improves LV systolic function and LV morphology in heart failure post-myocardial infarction in rats (1999) (0)
- Abstract 19925: Isolated Diastolic Hypotension is a Risk Factor for Incident Heart Failure in Community-Dwelling Older Adults with Wide Pulse Pressure (2010) (0)
- Abstract 18743: Lack of Evidence of Higher 30-day All-cause Readmission Among Older African American (vs. White) Medicare Beneficiaries Hospitalized for Heart Failure (2015) (0)
- OPTIMIZATION OF EVIDENCE-BASED THERAPIES FOR HEART FAILURE AND REDUCED EJECTION FRACTION PATIENTS IMPROVES OUTCOMES IN AN AMBULATORY SPECIALIZED SETTING (2020) (0)
- Effects Of Colchicine On Inflammation, Myocardial Damage And Microvascular Dysfunction In Men And Women With Heart Failure With Preserved Ejection Fraction (2023) (0)
- 499: Impact of Baseline RV Structural and Functional Abnormalities on the Presence of Cardiac Dyssynchrony: Insight from the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) TRIAL (2010) (0)
- CAN CARE GAPS IN ADHERENCE TO GUIDELINES THERAPY IN AN OUTPATIENT SPECIALIZED HEART FAILURE SETTING BE EXPLAINED BY CLINICAL AND PHYSIOLOGICAL FACTORS RATHER THAN CLINICAL INERTIA (2019) (0)
- SELF-REPORTED LOWER EXTREMITY EDEMA IN THE ABSENCE OF HEART FAILURE IS AN INDEPENDENT RISK FACTOR FOR INCIDENT HEART FAILURE AMONG COMMUNITY-DWELLING OLDER ADULTS (2015) (0)
- 460 Characterization and Functional Implications of Heart Rate Increase at the Onset of Exercise Testing and Heart Rate Recovery in Patients with Advanced Heart Failure (2012) (0)
- Abstract 17121: Initiation of Anti-Hypertensive Therapy and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) and a History of Hypertension (HTN) (2020) (0)
- Beneficial Effect of Mtor Inhibitors on Inflammation in Human Neutrophils (2013) (0)
- Reduced pulmonary clearance of endothelin-1 in patients with congestive heart failure (2003) (0)
- Persistent Elevation of Vascular Endothelial Growth Factor and Prostacyclin Following Cardiopulmonary Maladaptation to High Altitude: A Pilot study (2007) (0)
- Adverse Outcomes With Use of Hydralazine and Nitrate Combination Therapy in Hospitalized Older Non-black Patients With Heart Failure and Reduced Ejection Fraction (HFREF) (2017) (0)
- Abstract P171: Potential Mortality Reduction with Optimal Usage of sacubitril/valsartan Therapy for the Treatment of Heart Failure in Canada (2017) (0)
- Abstract 20091: Instrumental Activities of Daily Living Impairment is an Independent Predictor of Incident Heart Failure, Acute Myocardial Infarction and All-Cause Mortality in Community-Dwelling Older Adults (2010) (0)
- Effects of COLchicine on inflammation, myocardial damage and microvascular dysfunction in heart failure with Preserved Ejection Fraction – the COLpEF trial (2023) (0)
- [What is new in the medical management of acute heart failure?]. (2010) (0)
- HEART FAILURE WITH PRESERVED EJECTION FRACTION The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart FailureWith Preserved Ejection Fraction Results From the I-PRESERVE Trial ( Irbesartan in Heart Failure and Preserved Ejection Fraction ) (2017) (0)
- Current Smoking and a “Non-Paradoxical” Association with Mortality among Community-Dwelling Older Heart Failure Patients: Findings From the Cardiovascular Health Study (2016) (0)
- CLINICAL EFFECTIVENESS OF SPIRONOLACTONE IN HOSPITALIZED OLDER ELIGIBLE (EF LESS THAN OR EQUAL TO 35% AND EGFR GREATER THAN OR EQUAL TO 30 ML/MIN/1.73 M2) PATIENTS WITH HEART FAILURE (2017) (0)
- Abstract 20752: Clinical Effectiveness of Digoxin in Hospitalized Older Patients With Heart Failure and Preserved Ejection Fraction: A Propensity-Matched Study of Medicare-Linked OPTIMIZE-HF (2016) (0)
- Abstract 2912: Effect of {beta}1 389 Arg/Gly {alpha}2c 322 325 Wt/Del Genotypes on Adjudicated Hospitalizations in the BEST Trial (2007) (0)
- Cerebral And Cardiac Hemodynamics During Exercise Are Related To Cognitive Function In Heart Transplant Recipients: 921 Board #237 June 1, 2: 00 PM - 3: 30 PM. (2016) (0)
- THE IMPACT OF LEFT VENTRICULAR VERSUS SIMULTANEOUS BIVENTRICULAR PACING ON STRUCTURAL AND BIOCHEMICAL REVERSE REMODELING IN PATIENTS WITH HEART FAILURE: INSIGHTS FROM THE EVALUATION OF RESYNCHRONIZATION THERAPY FOR HEART FAILURE (EARTH) TRIAL (2015) (0)
- Growth Differentiation Factor-15 as a Predictor of Functional Capacity, Frailty, and Ventricular Dysfunction in Patients With Aortic Stenosis and Preserved Left Ventricular Ejection Fraction. (2022) (0)
- 500: The Impact of Baseline Cardiac Structural and Functional Abnormalities on Exercise Capacity: Insight from the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial (2010) (0)
- CHARACTERIZATION OF CIRCULATING AND NEUTROPHIL DERIVED PRO- AND ANTI-INFLAMMATORY BIOMARKERS IN PATIENTS WITH VARIOUS HEART FAILURE PHENOTYPES (2016) (0)
- Abstract 16531: Absence of Remodeling Benefit of Lv-crt Over Bv-crt in Patients With Heart Failure and Wide Qrs: Insight From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial (2011) (0)
- Oxidative stress and use of antioxidants in patients with congestive heart failure. (2000) (0)
- 507 Acute heart failure: A comparison of preserved and reduced ejection fraction in the emergency department (2011) (0)
- GDF-15 IS ASSOCIATED WITH FUNCTIONAL CAPACITY & VENTRICULAR DYSFUNCTION IN PATIENTS WITH MODERATE TO SEVERE AORTIC STENOSIS & PRESERVED EJECTION FRACTION (2019) (0)
- Does the Effect of Beta-Blockers on Outcomes in Patients with Advanced Chronic Systolic Heart Failure Vary by Baseline Systolic Blood Pressure? Insights from the BEST Trial (2010) (0)
- P5356Left atrial deformation in patients with moderate to severe aortic stenosis and heart failure (2018) (0)
- CANADIAN EXPERIENCE WITH THE SYNCARDIA TEMPORARY TOTAL ARTIFICIAL HEART AS BRIDGE TO TRANSPLANTATION (2015) (0)
- Upregulation on cardiac AT1 receptor density by combination treatment of ACE-inhibitor and β-adrenergic blocker in aged rats post-myocardial infarction (1999) (0)
- Biomarkers Monitoring for Absence of Acute Allograft Rejection (2016) (0)
- Palpitations Revealing a Primary Pulmonary Artery Sarcoma (2021) (0)
- BLOOD PRESSURE AND ATRIAL FIBRILLATION: A COMBINED ATRIAL FIBRILLATION-CONGESTIVE HEART FAILURE AND ATRIAL FIBRILLATION FOLLOW-UP INVESTIGATION OF RHYTHM MANAGEMENT ANALYSIS (2013) (0)
- Abstract 15826: Impact of the Type of Pattern of Intra-LV Dyssynchrony in Patients Randomized to Two Modes of CRT (LV vs. BiV): Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial (2010) (0)
- Thirty-year trends and outcome of isolated versus combined group 2 pulmonary hypertension after cardiac transplantation (2022) (0)
- Role of Neurohumoral Modulation in Congestive Heart Failure: Focus on the New Generation Calcium Channel Blockers (2018) (0)
- Health Care Use Among Incident Cases of Heart Failure: A Population-Based Cohort Study from 1997 To 2010 (2017) (0)
- Beta-Blocker Type Effect on Substrate Oxidation during HIIE in Heart Failure Patients: Pilot Data (2019) (0)
- 385 Impact of Immunosuppressive Agents on Neutrophils Inflammatory Response in Humans (2012) (0)
- OPTIMAL USAGE OF SACUBITRIL/VALSARTAN FOR HEART FAILURE TREATMENT IN CANADA POTENTIALLY REDUCES HOSPITALIZATIONS AND EARLY DISCHARGE RE-ADMISSIONS (2017) (0)
- HEARTBIT: A Novel Biosignature for Detection of Acute Cellular Rejection of Heart Allografts (2018) (0)
- DECREASED CIRCULATING AND NEUTROPHIL MEDIATED VEGF RELEASE IN STABLE LONG-TERM CARDIAC TRANSPLANT RECIPIENTS (2014) (0)
- Abstract 500: Basal Peripheral Arterial Blood Flow Increases Concomitantly with Decreased Cardiopulmonary Reserve and Biomarkers Activation in Patients with Heart Failure and Preserved Ejection Fraction (2013) (0)
- Early treatment with an ACE inhibitor after large myocardial infarctions provides similar improvement in resting and β-modulated function in young and older rats (1998) (0)
- Rapid Weaning of Steroids after Cardiac Transplantation Improves Outcomes. (2020) (0)
- P-438: Mitogen-activated protein (MAP) kinase signaling through calcineurin-dependent pathways in cardiac fibroblasts (2005) (0)
- Characterization and Functional Implications of Heart Rate Increase and Heart Rate Recovery on Maximal and Submaximal Exercise Capacity in Patients with Advanced Heart Failure (2014) (0)
- 493 Risk Factors for Renal Dysfunction Following Cardiac Transplantation (2012) (0)
- 510 Baseline characteristics, hemodynamic, clinical and biochemical response to candesartan in a prospective, multicenter pharmacogenomic study of heart failure patients already receiving an ace inhibitor (2011) (0)
- Characterization and Modulation of Neutrophils Inflammatory Response in Advanced Heart Failure (2013) (0)
- The Role of Digoxin in Heart Failure (2020) (0)
- 370 Increase Inflammation, Oxidative Stress and Basal Peripheral Arterial Blood Flow in Ambulatory Patients Suffering from Heart Failure With Preserved Ejection Fraction (2012) (0)
- Right Ventricular Function Coupling to the Pulmonary Circulation Predicts Exercise Tolerance in Patients with Heart Failure and Reduced Ejection Fraction. Insight from the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial. (2020) (0)
- Decreased submaximal exercise tolerance and increased sympathetic activation in response to cold exposure in patients with congestive heart failure (1999) (0)
- Protocol An Internet-Based Counseling Intervention With Email Reminders that Promotes Self-Care in Adults With Chronic Heart Failure : Randomized Controlled Trial Protocol (2016) (0)
- Admission Electrocardiogram Diagnosed Atrial Fibrillation is Independently Associated with 30-Day All-Cause Readmission in Older Medicare Beneficiaries Hospitalized for Heart Failure (2016) (0)
- Clinical Research Differences in Biomarkers in Patients With Heart Failure With a Reduced vs a Preserved Left Ventricular Ejection Fraction (2012) (0)
- Subclinical inflammation and prothrombotic state in stable long-term heart transplant recipients with treated but persistent mild dyslipidemia: impact of cyclosporin microemulsion versus tacrolimus (2004) (0)
- Pregnancy After Heart Transplantation: A Well-Thought-Out Decision? (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Michel White?
Michel White is affiliated with the following schools:
